These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23719667)

  • 1. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.
    Bargellini I; Florio F; Golfieri R; Grosso M; Lauretti DL; Cioni R
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):438-44. PubMed ID: 23719667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in endovascular therapy to treat primary hepatocellular carcinoma.
    Guo Z; Yu H; Liu C; Si T; Yang X; Zhang W; Xu Y; Li Y
    Drug Discov Ther; 2015 Oct; 9(5):342-51. PubMed ID: 26632543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Young S; Craig P; Golzarian J
    Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapy of hepatocellular carcinoma with special consideration of new and multimodal treatment concepts].
    Göbel T; Blondin D; Kolligs F; Bölke E; Erhardt A
    Dtsch Med Wochenschr; 2013 Jul; 138(27):1425-30. PubMed ID: 23801265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Vogl TJ; Gruber-Rouh T
    Dig Dis Sci; 2019 Apr; 64(4):959-967. PubMed ID: 30835030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
    Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
    Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
    Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization and radioembolization.
    Sangro B; Salem R
    Semin Liver Dis; 2014 Nov; 34(4):435-43. PubMed ID: 25369305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic interventional radiology procedures in hepatocellular carcinoma].
    Huppert PE; Viebahn R; Duda SH; Lauchart W
    Zentralbl Chir; 1994; 119(11):787-93. PubMed ID: 7531377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
    Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
    J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Li Y; Ji H; Zhao X; Lu H
    Biosci Trends; 2015 Oct; 9(5):289-98. PubMed ID: 26559021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization for Treatment of Hepatocellular Carcinoma - National Registry-Based Analysis.
    Rohan T; Andrašina T; Uher M; Matkulčík P; Zavadil J; Staňková M; Čechová B; Jandurová L; Válek V
    Klin Onkol; 2019; 32(Supplementum1):160-163. PubMed ID: 31064189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
    Giannini EG; Bodini G; Corbo M; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Aliment Pharmacol Ther; 2010 Feb; 31(4):493-501. PubMed ID: 19912152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.